Geriatric Population Drives The Stem Cell Manufacturing Market: An Emerging Driver Transforming The Stem Cell Manufacturing Market Landscape

The Stem Cell Manufacturing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Stem Cell Manufacturing Market Size and Projected Growth Rate?
The market size for stem cell manufacturing has seen significant expansion in the past few years. There is an expected escalation from $17.5 billion in 2024 to $19.22 billion in 2025, progressing at a compound annual growth rate (CAGR) of 9.8%. The prior growth period's expansion is primarily due to advancements in biotechnology, research and development efforts, clinical trials, therapeutic use, establishment of regulatory structures, and infrastructural investment.

In the upcoming years, the stem cell manufacturing market is poised for substantial expansion. The market is projected to surge to $30.27 billion by 2029, with a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this growth during the predicted period include enhanced funding and investment, the proliferation of therapeutic applications, the advent of cell-based therapies, an increase in clinical trials and approvals, and the development of personalized, patient-centric therapies. Key trends for the forecast period encompass a focus on 3D bioprinting, the multiplication of induced pluripotent stem cells (iPSCs), the incorporation of automation and robotics, standardization and scalability, and advancements in bioreactor technology.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9402

What Are the Different Stem Cell Manufacturing Market Segments?
The stem cell manufacturing market covered in this report is segmented -

1) By Product: Consumables, Instruments, Stem Cell Lines
2) By Application: Research Applications, Clinical Application, Cell And Tissue Banking Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Research Laboratories And Contract Research Organizations, Hospitals And Surgical Centers, Cell And Tissue Banks, Other End Users

Subsegments:
1) By Consumables: Media And Reagents, Cell Culture Vessels, Assay Kits
2) By Instruments: Bioreactors, Cell Counters, Flow Cytometers
3) By Stem Cell Lines: Embryonic Stem Cell Lines, Adult Stem Cell Lines, Induced Pluripotent Stem Cell Lines (iPSCs)

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9402&type=smp

What Are the Primary Drivers Shaping the Stem Cell Manufacturing Market?
An increase in the older population, referred to as the geriatric population (individuals aged 65 and above), is anticipated to significantly elevate the stem cell manufacturing market. Older adults are more susceptible to various illnesses due to decreased immunity and advanced age. As aging enhances the likelihood of chronic diseases, stem cell manufacturing may provide efficacious solutions to combat these ailments. To illustrate, the Population Reference Bureau, a nonprofit entity in Kenya, projected in January 2024 that the American population aged 65 and older would surge from 58 million in 2022 to 82 million by 2050. This shows an increase of 47%. Furthermore, this demographic's percentage of total population is predicted to expand from 17% to 23% within the same duration. Consequently, the expanding population of older adults is contributing to the growth of the stem cell manufacturing market.

Which Companies Are Leading in the Stem Cell Manufacturing Market?
Major companies operating in the stem cell manufacturing market include Thermo Fisher Scientific Inc., Merck Millipore, Stemcell Technologies, Fujifilm Holdings Corporation, Takara Bio Group, Lonza Group AG, Sartorius AG, Bio-Rad Laboratories, Becton Dickinson and Company, Bio-Techne Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Eppendorf AG, ViaCyte Inc., Merck KGaA, Danaher Corporation, Vericel Corporation, American Cryostem Corporation, Cellgenix GMBH, Aspen Neuroscience Inc., Magenta Therapeutics Inc, Pluristem Therapeutics Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., 3D Biomatrix Inc., Worthington Biochemical Corporation, Bico Group

What Are the Major Trends Shaping the Stem Cell Manufacturing Market?
A noteworthy trend in the stem cell production industry is the integration of advanced technology. Numerous market participants aim to adopt innovative solutions to maintain their market presence. To illustrate, Bluebird Bio Inc., a biotechnology firm based in the US, revealed in August 2022 that they had received approval from the U.S. Food and Drug Administration (FDA) for ZYNTEGLO. This groundbreaking gene therapy, which is now sanctioned for use in treating beta-thalassemia patients requiring regular red blood cell transfusions, showcases an ex-vivo approach. This involves the incorporation of a modified beta-globin gene into the patient's hematopoietic stem cells, facilitating the production of regular amounts of hemoglobin. The therapy's primary goal is to eliminate the need for transfusions, substantially reducing the treatment difficulty experienced by beta-thalassemia patients. The approval of ZYNTEGLO denotes a significant landmark in the domain of gene therapy, potentially providing a cure and improving life quality for those suffering from this condition.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report

What Are the Top Revenue-Generating Geographies in the Stem Cell Manufacturing Market?
North America was the largest region in the stem cell manufacturing market in 2024. Europe was the second-largest region in the stem cell manufacturing market. The regions covered in the stem cell manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Stem Cell Manufacturing Market?
2. What is the CAGR expected in the Stem Cell Manufacturing Market?
3. What Are the Key Innovations Transforming the Stem Cell Manufacturing Industry?
4. Which Region Is Leading the Stem Cell Manufacturing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.